Opaleye Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.8M Buy
+1,051,901
New +$15.7M 2% 16

Other funds holding SMMT

Opaleye Management's SMMT Position: Q3 2026 in Review

Opaleye Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 1,051,901 shares worth $17.8M. The stake represents 2% of the portfolio and ranks #16 among its holdings.

295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Opaleye Management held 1,051,901 shares of Summit Therapeutics worth $17.8M as of Q3 2026.
  • Summit Therapeutics was a new Opaleye Management position in Q3 2026.
  • Summit Therapeutics made up 2% of Opaleye Management's portfolio in Q3 2026, its #16 holding.
  • 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.